Xanthinol Nicotinate Tablets
Function and Efficacy
This product is a vasodilator that directly acts on the smooth muscle of arterioles and capillaries, dilates blood vessels, improves blood rheology, and reduces peripheral vascular resistance. This product can promote glucose to pass through the blood-brain barrier, enhance the use of glucose and oxygen in brain cells, improve brain sugar metabolism and brain function. It also promotes fat metabolism and reduces hyperlipidemia, high cholesterol, and high fibrinogen.
Ingredients
The main ingredient of this product is nicotinate xanthinol, chemical name: 7[2-hydroxy-3-(2-hydroxyethyl-methylamino)]theophylline nicotinate. Molecular formula: C13H21N5O4C6H5NO2 Molecular weight: 434.45
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Xanthinol nicotinateIngredients |
This product is a vasodilator that directly acts on the smooth muscle of arterioles and capillaries, dilates blood vessels, improves blood rheology, and reduces peripheral vascular resistance. This product can promote glucose to pass through the blood-brain barrier, enhance the use of glucose and oxygen in brain cells, improve brain sugar metabolism and brain function. It also promotes fat metabolism and reduces hyperlipidemia, high cholesterol, and high fibrinogen. More |
437-74-1 | 9 |
Appearance
White tablets.
Indication
Used for ischemic cerebrovascular disease and its sequelae; also used for thromboangiitis obliterans, phlebitis, etc.
Usage and Dosage
Oral administration: 100-200 mg (1-2 tablets) at a time, 3 times a day, after meals.
Adverse Reactions
A small number of people experience some minor reactions after taking the medicine, such as facial flushing (mainly on the face and upper body), mild skin allergies, itching, etc., which are all mild and generally disappear on their own, do not affect the treatment, and can be avoided by taking the medicine after meals.
Precautions
1. It is contraindicated for patients with myocardial infarction, mitral stenosis and heart failure due to compensatory dysfunction. 2. It is contraindicated for patients with acute hemorrhagic cerebrovascular disease. 3. It is contraindicated for patients with acute hemorrhagic diseases.
Drug Interactions
It should not be used simultaneously with ganglion blockers and sympathetic anti-drugs.
Storage
Seal tightly and store in a cool place.
Packaging Specification
0.1g
Manufacturer
Shanxi JINXIN DOUBLE-CRANE Pharmaceutical Co., Ltd.
-
Founded in:
2001-12-14 -
Address:
Sanlidun, North of Xia County, Yuncheng City, Shanxi Province -
Tax NO.:
911408287281430205 -
Registered Funds:
164.191 million yuan -
Website:
-
Email: